戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 o15-4513 binding at the diazepam-insensitive benzodiazepine receptor.
2 -dependent protein kinase and the peripheral benzodiazepine receptor.
3 ear independent of binding to the peripheral benzodiazepine receptor.
4  ligand of the mitochondrial peripheral-type benzodiazepine receptor.
5 an antagonist and partial inverse agonist of benzodiazepine receptor.
6 ng component of the mitochondrial peripheral benzodiazepine receptor.
7 achieve sustained binding equilibrium at the benzodiazepine receptors.
8 e binding of RU34347 to diazepam-insensitive benzodiazepine receptors.
9  receptor in the brain and to peripheral 1,4 benzodiazepine receptors.
10 PET imaging with (18)F-FDG, (18)F-peripheral benzodiazepine receptor ((18)F-PBR), and (18)F-florbetap
11 195) is a ligand specific for the peripheral benzodiazepine receptor abundant on macrophages and is e
12 n by bilateral intra-basalis infusion of the benzodiazepine receptor agonist chlordiazepoxide (40 mic
13  interventions, the most evidence exists for benzodiazepine receptor agonist drugs, although persiste
14                   A separate concern is that benzodiazepine receptor agonist hypnotics can cause para
15            Intravenous administration of the benzodiazepine receptor agonist midazolam, resulted in a
16                               The peripheral benzodiazepine receptor agonist PK11195 induced RGC deat
17  We have recently reported that midazolam, a benzodiazepine receptor agonist that is also a short act
18                        Pretreatment with the benzodiazepine receptor agonist, diazepam (5 mg/kg), abo
19                                          The benzodiazepine receptor agonist, midazolam (1 and 2 micr
20 e with beta-carboline, an anxiogenic inverse benzodiazepine receptor agonist, normalized alcohol pref
21 ilitation of wake-promoting systems, whereas benzodiazepine receptor agonists (BzRAs) such as zolpide
22                                              Benzodiazepine receptor agonists included zolpidem, zopi
23 to assess the efficacy of benzodiazepines or benzodiazepine receptor agonists or behavioral treatment
24                             Barbiturates and benzodiazepine receptor agonists, for example, both pote
25 ls of self-administration than non-selective benzodiazepine receptor agonists.
26 Insomnia treatments include benzodiazepines, benzodiazepine-receptor agonists, and cognitive behaviou
27 ction of StAR remain unclear; the peripheral benzodiazepine receptor, an OMM protein, appears to be i
28           This suggests an interplay between benzodiazepine receptors and delta-opioid receptors in r
29 istribution volume are consistent with fewer benzodiazepine receptors and/or reduced affinity of rece
30  propofol alone, and in combination with the benzodiazepine receptor antagonist flumazenil, into the
31            Intravenous administration of the benzodiazepine receptor antagonist flumazenil, resulted
32 47 microM, alone and in combination with the benzodiazepine receptor antagonist flumazenil, which has
33  function, the mice were challenged with the benzodiazepine receptor antagonist, flumazenil.
34 keys were prevented by pretreatment with the benzodiazepine receptor antagonist, RO15-1788, which blo
35  fully antagonised by 1 microM flumazenil, a benzodiazepine receptor antagonist.
36 ime-dependent regulation of cortical GABA(A)-benzodiazepine receptors associated with the recovery fr
37  report that Dexras1 binds to the peripheral benzodiazepine receptor-associated protein (PAP7), a pro
38 it was first characterized as the peripheral benzodiazepine receptor because it appears to be respons
39  subjects, a quantitative measure related to benzodiazepine receptor binding (distribution volume) wa
40             Focal increases and decreases in benzodiazepine receptor binding have been demonstrated i
41             No studies have examined central benzodiazepine receptor binding in patients with posttra
42 ose of this study was to examine measures of benzodiazepine receptor binding in PTSD.
43 mals exposed to stress exhibit a decrease in benzodiazepine receptor binding in the frontal cortex.
44 monstrated reduced dopamine D2 and increased benzodiazepine receptor binding in the striatum of HD an
45                                      Reduced benzodiazepine receptor binding is commonly seen at an e
46       These findings of lower values for the benzodiazepine receptor binding measure of distribution
47 To identify potential abnormalities of brain benzodiazepine receptor binding number and distribution
48                               The density of benzodiazepine receptor binding was also increased in th
49 w visualization of a quantitative measure of benzodiazepine receptor binding, are reported to have hi
50 Other agents, such as cyclosporin A and some benzodiazepine receptor-binding agents, have been found
51 adenosine, alone and in combination with the benzodiazepine receptor blocker flumazenil, into the MPA
52 r range, show selectivity toward the central benzodiazepine receptor (BzR) and exhibit structure-affi
53          Increased activation of the central benzodiazepine receptor (BZR) appears to play an importa
54 rontoparietal ACh efflux alone, and with the benzodiazepine receptor (BZR) weak inverse agonist ZK 93
55 ives was designed and synthesized as central benzodiazepine receptor (CBR) ligands.
56 e have previously shown reduction of central benzodiazepine receptor (cBZR) binding restricted to the
57  previously shown that reductions of central benzodiazepine receptors (cBZRs) are restricted to the h
58 outflow of glutamate, and implicate the GABA/benzodiazepine receptor complex in the stress-induced ac
59 h affinity for the gamma-aminobutyric acid A/benzodiazepine receptor complex was developed.
60 ty for the gamma-aminobutyric acid A (GABAA)/benzodiazepine receptor complex with efficacies ranging
61  urea series had high affinity for the GABAA/benzodiazepine receptor complex with varying in vitro ef
62  of chloride channel function in the GABA(A)-benzodiazepine receptor complex, or increases in neurona
63 ce through chloride channels coupled to GABA-benzodiazepine receptor complex.
64 by direct or indirect actions on the GABA(A)-benzodiazepine receptor complex.
65 al seizures, to quantify the GABA(A)-central benzodiazepine receptor complex.
66 his is related to its effects on the GABA(A)-benzodiazepine receptor complex.
67 y a direct or indirect action on the GABA(A)-benzodiazepine receptor complex.
68  in part via agonist-like actions at GABA(A)/benzodiazepine receptor complexes in the ventral tegment
69  returns ligand binding to both the GABA and benzodiazepine receptor components of the GABAA receptor
70                          Cortical mapping of benzodiazepine receptor concentration ([(11) C]FMZ Bmax)
71  in gamma-aminobutyric acid type A (GABA(A))-benzodiazepine receptors contribute to the neurobiology
72                      Alterations in cortical benzodiazepine receptor density have been described in p
73 ntly that regions of increased and decreased benzodiazepine receptor density may be seen in patients
74                                              Benzodiazepine receptor distribution volume is significa
75 ography with [11C]flumazenil revealed normal benzodiazepine receptor distribution volumes, similar to
76               Gamma-aminobutyric acid (GABA)/benzodiazepine receptors, dopamine D1-like and D2-like r
77 ACBP required the presence of the peripheral benzodiazepine receptor (for which ACBP is a ligand) to
78 r partial agonist MRK-696, and non-selective benzodiazepine receptor full agonists, midazolam and lor
79                               Alterations in benzodiazepine receptor function in this area may underl
80 he reduced anxiety was due to differences in benzodiazepine receptor function, the mice were challeng
81 ted by ethanol-induced alteration of GABA(A)-benzodiazepine receptor function.
82     They measured the distribution volume of benzodiazepine receptors in 11 recently detoxified patie
83 e characterised the biphasic response of the benzodiazepine receptor inverse agonist RU34347 in the r
84 terial TspO and the mitochondrial peripheral benzodiazepine receptor is discussed.
85 ; TSPO), previously known as peripheral-type benzodiazepine receptor, is a high-affinity cholesterol-
86 n (TSPO), previously known as the peripheral benzodiazepine receptor, is a mitochondrial outer membra
87 PO), previously known as the peripheral-type benzodiazepine receptor, is an outer mitochondrial membr
88 PO) (18 kDa), formerly called the peripheral benzodiazepine receptor, is upregulated on activated mic
89                               Higher GABA(A)-benzodiazepine receptor levels during acute withdrawal m
90 we used positron emission tomography and the benzodiazepine receptor ligand flumazenil labeled with c
91 PET studies with a gamma-aminobutyric acid A-benzodiazepine receptor ligand, (11)C-flumazenil, and th
92 ecarboxamide (PK11195), a typical peripheral benzodiazepine receptor ligand, has been established as
93  in Pgp(+) AML cells and that the peripheral benzodiazepine receptor ligand, PK11195, sensitizes AML
94 n terms of therapeutic drug design, although benzodiazepine receptor ligands are an example of the se
95                                              Benzodiazepine receptor ligands that bound to the purifi
96 e rat mitochondrial outer membrane-localized benzodiazepine receptor (MBR) was expressed in wild-type
97 hannel (IMAC) modulated by the mitochondrial benzodiazepine receptor (mBzR).
98 pounds exhibit functional selectivity at the benzodiazepine receptor of GABA(A) receptor subtypes.
99 within this series had high affinity for the benzodiazepine receptor on the alpha-aminobutyric acid A
100 icate either a toxic effect of alcoholism on benzodiazepine receptors or a vulnerability factor for d
101                 These results suggest that a benzodiazepine receptor partial agonist may have greater
102 ere compared with those of the non-selective benzodiazepine receptor partial agonist MRK-696, and non
103 ive properties of the novel imidazoquinoline benzodiazepine receptor partial agonist, PNU-101017, in
104 olinesterase inhibitor physostigmine nor the benzodiazepine receptor partial inverse agonist FG 7142
105 ivity in the mPFC and BLA in response to the benzodiazepine receptor partial inverse agonist N-methyl
106 tein that interacts with the peripheral-type benzodiazepine receptor (PBR) and cAMP-dependent protein
107 tein that interacts with the peripheral-type benzodiazepine receptor (PBR) and the cAMP-dependent pro
108    To evaluate the utility of the peripheral benzodiazepine receptor (PBR) as a biomarker of neurotox
109 ir applications as nonradioactive peripheral benzodiazepine receptor (PBR) binding probes and photose
110                               The peripheral benzodiazepine receptor (PBR) has been used as a sensiti
111 he role of the mitochondrial peripheral-type benzodiazepine receptor (PBR) in steroidogenesis, we dev
112                              Peripheral-type benzodiazepine receptor (PBR) is an 18 kDa high-affinity
113                          The peripheral-type benzodiazepine receptor (PBR) is an Mr 18,000 protein pr
114 ts suggest that the mitochondrial peripheral benzodiazepine receptor (PBR) is not the cellular bindin
115 -carboxamide (PK11195), a typical peripheral benzodiazepine receptor (PBR) ligand, as a selective and
116                               The peripheral benzodiazepine receptor (pBR) ligand, PK11195, promotes
117 tiapoptotic mitochondrial protein peripheral benzodiazepine receptor (PBR) protects neonatal mice aga
118 the carboxyl terminus of the peripheral-type benzodiazepine receptor (PBR), an outer mitochondrial me
119 otein (TSPO), also referred to as peripheral benzodiazepine receptor (PBR), is a crucial 18-kDa outer
120  binding site, the so-called peripheral-type benzodiazepine receptor (PBR).
121                Elevated levels of peripheral benzodiazepine receptors (PBR) are associated with activ
122 ds for sensitive imaging of brain peripheral benzodiazepine receptors (PBR) in vivo.
123                                   Peripheral benzodiazepine receptors (PBRs) are located on the outer
124 ly developed radioligand to image peripheral benzodiazepine receptors (PBRs) in brain.
125 ), an antagonist to mitochondrial peripheral benzodiazepine receptors (PBRs), with bortezomib trigger
126                                   Peripheral benzodiazepine receptor (PBzR) agonists (PK11195, FGIN 1
127  photon emission computed tomography and the benzodiazepine receptor radiotracer [123I]iomazenil.
128 in (TSPO; previously known as the peripheral benzodiazepine receptor) remains unclear because its pre
129 ex II, voltage-dependent anion channels, and benzodiazepine receptor, respectively.
130 sitron-emitting ligand that binds peripheral benzodiazepine receptor sites in activated microglia--us
131 pha5beta3gamma2, and alpha6beta3gamma2 GABAA/benzodiazepine receptor subtypes are reported.
132 erial homolog of the mammalian mitochondrial benzodiazepine receptor, the tryptophan-rich sensory pro
133  (TSPO), previously known as peripheral-type benzodiazepine receptor; the TSPO-associated protein PAP
134             [3H]Flunitrazepam binding to the benzodiazepine receptor was enhanced by ammonium (10-500
135 Ro 15-1788 and [3H]Ro 15-4513 binding to the benzodiazepine receptor was not significantly enhanced b
136 tor with selectivity for the type-I (omega1) benzodiazepine receptor, was studied for efficacy in alt
137 lium has neither GABA(A) nor peripheral-type benzodiazepine receptors, we find that both a diazepam b
138                                         GABA/benzodiazepine receptors were unchanged either before or

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top